Global Life Science and Analytical Instruments Market To Reach $44.75 Billion By 2021

Published On: October 24, 2016

The global life science and analytical instruments market is expected to reach $48.48 billion by 2021 with a CAGR of 6.9% over the period of 2016 to 2021, according to latest publication by Meticulous Research™.

The last 5-6 years have been predominantly eventful for instrument companies with major mergers and acquisitions, partnerships, new product launches, and other business developments. With rising government spending on pharmaceutical R&D in emerging nations, increasing life science research and development expenditure, progressing drug discovery and clinical diagnostics field, technological advancements, emerging applications, growing aging populations, rising prevalence of chronic diseases, and changing demographics; numerous industry participants reported record sales primarily driven by the robust growth in emerging countries such as China, India, and Brazil. However, presence of alternative technologies and high cost of instruments are some of the key factors hampering the growth of this market.

The global life science and analytical instruments market is mainly segmented by product, end-user, and geography. Spectroscopy segment commanded the largest share in the global life science and analytical instruments market, followed by separation techniques such as liquid and gas chromatography. The comprehensive end-user analysis is provided in the report for each technology. The global life science and analytical instrumentation market is further segmented by geography into four major continents namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). These regions are further analyzed at a country level to provide the market size and forecast for each segment and sub-segment of the market in various countries across the globe. North America and Europe have been in the forefront of acknowledging the need for life science and analytical instruments in biopharmaceuticals and pharmaceuticals, followed by Asia-Pacific, Latin America, and Middle East & Africa.

The leading 40-50 life science and analytical instruments companies accounted for more than 70% share of the global market. These leading players further aims to expand in the global market through various mergers and acquisitions. key players in the global life science and analytical instrumentation market are Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.).

Key questions answered in the report-

Which are the high growth market segments in terms of life science and analytical instrumentation technologies,end users,regions, and countries?

What is the historical market for life science and analytical instrumentation across the globe?

What are the market forecasts and estimates from the period 2016-2021?

What are the major drivers, restrains, threats, and opportunities in the global life science and analytical instrumentation market?

What are the burning issues of the global life science and analytical instruments market?

Who are the major players in the global life science and analytical instrumentation market and what share of the market do they hold?

Who are the major players in various regions (North America, APAC, Europe, Latin America, and Middle East & Africa) and what share of the market do they hold?

What are the competitive landscapes and who are the market leaders by sub-region in the global life science and analytical instruments market?

What are the recent developments in the global life science and analytical instruments market?

What are the different strategies adopted by the major players in the global life science and analytical instrumentation market?

What are the geographical trends and high growth regions/ countries?

About Meticulous Research™

Meticulous Research™ is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research™ produces global reports and custom studies for North America, Europe, Latin America, Asia¬-Pacific, and Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Select License Type

Single User -

Multiple User -

Corporate User -

License Details

Single User:

With the help of Single User License, only an individual can use our report either electronically or online. The right to use of the report should be confined only to one authorized computer. Upon buying single user license, buyer must provide the names and email ids of the authorized users of this report.

Multi Users:

Multi-User license permits to access the report from five authorized computers. It does not permit you to share the report with other divisions and subsidiaries of the same company. Upon buying multi-user license, buyer must provide the names and email ids of the authorized users of this report.

Corporate User

With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report is prohibited without the prior permission of Meticulous Research.

Dating back from 1970’s, it is believed that use of barcode technology in various healthcare settings has reduced the medication errors and the cost incurred in rehabilitating the patient after the wrong treatment. The adoption of such advanced technologies in the healthcare sector will drastically enhance the operations of hospitals or other healthcare systems.

According to the Journal of Patient Safety, around 400,000 deaths occur each year in the U.S. only. It also reveals that each year preventable adverse events (PAEs) lead to the death of 210,000-400,000 patients who seek care at a hospital.

Corn is the leading source of starch extraction. The corn plant has large capacity for efficiently converting large amounts of radiant energy from the sun into stable chemical energy. This energy is stored as cellulose, oil, and starch in the corn plant and in the corn kernel. The corn plant is also one of nature's greatest multipliers.

Pharmaceutical industry has grown in leaps and bounds during the last three to four decades. Initial emphasis on validation of tablets started across the industry globally sometime in late sixties or early seventies.